Type |
Details |
Score |
Interaction Experiment |
Description: |
CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. |
|
•
•
•
•
•
|
Publication |
First Author: |
Santos L |
Year: |
2019 |
Journal: |
Sci Rep |
Title: |
A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo. |
Volume: |
9 |
Issue: |
1 |
Pages: |
14381 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nakazawa H |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
iNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-κB and p53. |
Volume: |
12 |
Issue: |
1 |
Pages: |
e0170391 |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. |
|
•
•
•
•
•
|
Allele |
Name: |
collagen, type I, alpha 1; targeted mutation 1, Peter Y Chuang |
Allele Type: |
Targeted |
Attribute String: |
Knockdown, Reporter, RMCE-ready |
|
•
•
•
•
•
|
Allele |
Name: |
sirtuin 1; targeted mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 1, Makoto Kinoshita |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhao W |
Year: |
2008 |
Journal: |
Nature |
Title: |
Negative regulation of the deacetylase SIRT1 by DBC1. |
Volume: |
451 |
Issue: |
7178 |
Pages: |
587-90 |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
The type III histone deacetylase Sirt1 suppresses p300- mediated histone H3 Lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Reciprocal roles of SIRT1 and SKIP in the regulation of RAR activity: implication in the retinoic acid-induced neuronal differentiation of P19 cells. |
|
•
•
•
•
•
|
Publication |
First Author: |
Lai Y |
Year: |
2017 |
Journal: |
J Cell Sci |
Title: |
Lipopolysaccharide modulates p300 and Sirt1 to promote PRMT1 stability via an SCFFbxl17-recognized acetyldegron. |
Volume: |
130 |
Issue: |
20 |
Pages: |
3578-3587 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhao X |
Year: |
2005 |
Journal: |
Mol Cell Biol |
Title: |
Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. |
Volume: |
25 |
Issue: |
19 |
Pages: |
8456-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang T |
Year: |
2009 |
Journal: |
J Biol Chem |
Title: |
Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters. |
Volume: |
284 |
Issue: |
30 |
Pages: |
20408-17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang H |
Year: |
2022 |
Journal: |
Exp Ther Med |
Title: |
miR‑141 impairs mitochondrial function in cardiomyocytes subjected to hypoxia/reoxygenation by targeting Sirt1 and MFN2. |
Volume: |
24 |
Issue: |
6 |
Pages: |
763 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ding Y |
Year: |
2019 |
Journal: |
Arterioscler Thromb Vasc Biol |
Title: |
Peroxynitrite-Mediated SIRT (Sirtuin)-1 Inactivation Contributes to Nicotine-Induced Arterial Stiffness in Mice. |
Volume: |
39 |
Issue: |
7 |
Pages: |
1419-1431 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion A, Manuel Serrano |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Senawong T |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. |
Volume: |
278 |
Issue: |
44 |
Pages: |
43041-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Senawong T |
Year: |
2005 |
Journal: |
Arch Biochem Biophys |
Title: |
BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. |
Volume: |
434 |
Issue: |
2 |
Pages: |
316-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sundaresan NR |
Year: |
2011 |
Journal: |
Sci Signal |
Title: |
The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. |
Volume: |
4 |
Issue: |
182 |
Pages: |
ra46 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE22530 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE13120 |
Experiment Type: |
transcription profiling by array |
Study Type: |
Baseline |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Cell cycle and apoptosis regulator protein 2 (CCAR2, also known as DBC-1) regulates biological processes such as transcription, heterochromatin formation, metabolism, mRNA splicing, apoptosis, and cell proliferation []. It is a core component of the DBIRD complex, which affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions []. It binds to SIRT1 and is a negative regulator of SIRT1 []. DBC-1 has been implicated in tumorigenesis []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Meng F |
Year: |
2020 |
Journal: |
Elife |
Title: |
Synergy between SIRT1 and SIRT6 helps recognize DNA breaks and potentiates the DNA damage response and repair in humans and mice. |
Volume: |
9 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Dey S |
Year: |
2008 |
Journal: |
Carcinogenesis |
Title: |
Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells. |
Volume: |
29 |
Issue: |
10 |
Pages: |
1920-9 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, transgenic |
|
•
•
•
•
•
|
Allele |
Name: |
sirtuin 1; endonuclease-mediated mutation 1, Daniel Herranz |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Sirt1)ASrn/? |
Background: |
involves: C57BL/6 * CBA |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Allele |
Name: |
sirtuin 1; targeted mutation 3.1,Michael W McBurney |
Allele Type: |
Targeted |
Attribute String: |
Hypomorph, Inducible |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE62194 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim JE |
Year: |
2008 |
Journal: |
Nature |
Title: |
DBC1 is a negative regulator of SIRT1. |
Volume: |
451 |
Issue: |
7178 |
Pages: |
583-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim W |
Year: |
2013 |
Journal: |
Cancer Lett |
Title: |
Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage. |
Volume: |
333 |
Issue: |
2 |
Pages: |
180-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim JE |
Year: |
2009 |
Journal: |
Cell Cycle |
Title: |
p30 DBC is a potential regulator of tumorigenesis. |
Volume: |
8 |
Issue: |
18 |
Pages: |
2932-5 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Sirt1/Sirt1 |
Background: |
involves: 129/Sv * 129S1/Sv * 129S4/SvJae * 129X1/SvJ |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE17067 |
Experiment Type: |
transcription profiling by array |
Study Type: |
Baseline |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE67239 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang W |
Year: |
2010 |
Journal: |
Oncogene |
Title: |
A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1. |
Volume: |
29 |
Issue: |
17 |
Pages: |
2467-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Van Rechem C |
Year: |
2009 |
Journal: |
J Biol Chem |
Title: |
Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1). |
Volume: |
284 |
Issue: |
31 |
Pages: |
20927-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pinte S |
Year: |
2004 |
Journal: |
J Biol Chem |
Title: |
The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties. |
Volume: |
279 |
Issue: |
37 |
Pages: |
38313-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Van Rechem C |
Year: |
2010 |
Journal: |
Mol Cell Biol |
Title: |
Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells. |
Volume: |
30 |
Issue: |
16 |
Pages: |
4045-59 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Hypermethylated in cancer 1 (HIC1) is a transcriptional repressor that modulates P53-dependent and E2F1-dependent cell growth control and is epigenetically inactivated in various human cancers []. It recognises and binds to the consensus sequence '5-[CG]NG[CG]GGGCA[CA]CC-3' []. It is a direct transcriptional repressor of ephrin-A1 and CXCR7, which are implicated in the pathogenesis of different cancers [, ]. HIC1 is also involved in down-regulation of SIRT1 and thereby is involved in regulation of p53/TP53-dependent apoptotic DNA-damage responses []. HIC1 interacts with several different corepressors such as CTBP1, CTBP2 and MTA1 (a subunit of the NuRD complex) []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This group represents a core histone macro-H2A.MacroH2A is a variant of the major-type core histone H2A which contains an N-terminal H2A domain and a C-terminal nonhistone macro domain. Histone macroH2A is enriched on the inactive X chromosome of mammalian female cells []. It does not bind poly ADP-ribose, but does bind the monomeric SirT1 metabolite O-acetyl-ADP-ribose (OAADPR) with high affinity through its macro domain []. In addition, the macro domain of macroH2A associates with histone deacetylases and affects the acetylation status of nucleosomes. MacroH2A-containing nucleosomes are repressive toward transcription []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim JH |
Year: |
2008 |
Journal: |
Mol Cell |
Title: |
CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. |
Volume: |
31 |
Issue: |
4 |
Pages: |
510-9 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
92
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
161
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Cell division cycle and apoptosis regulator protein 1 (CCAR1) associates with components of the Mediator and p160 coactivator complexes that play a role as intermediaries transducing regulatory signals from upstream transcriptional activator proteins to basal transcription machinery. CCAR1 also functions as a p53 coactivator and regulates expression of key proliferation-inducing genes [].Cell cycle and apoptosis regulator protein 2 (CCAR2, also known as DBC-1) regulates biological processes such as transcription, heterochromatin formation, metabolism, mRNA splicing, apoptosis, and cell proliferation []. It is a core component of the DBIRD complex, which affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions []. It binds to SIRT1 and is a negative regulator of SIRT1 []. DBC-1 has been implicated in tumorigenesis [].This entry also includes protein SHORT ROOT IN SALT MEDIUM 1 (RSA1, also known as EMB1579) from Arabidopsis. It regulates the transcription of several genes involved in the detoxification of reactive oxygen species generated by salt stress and the SOS1 gene that encodes a plasma membrane Na(+)/H(+) antiporter essential for salt tolerance []. RSA1 is localised to the nucleus and the loss of function of RSA1 affects global transcription and mRNA splicing []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Christophorou MA |
Year: |
2014 |
Journal: |
Nature |
Title: |
Citrullination regulates pluripotency and histone H1 binding to chromatin. |
Volume: |
507 |
Issue: |
7490 |
Pages: |
104-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ito T |
Year: |
2012 |
Journal: |
Cancer Cell |
Title: |
aSIRTing control over cancer stem cells. |
Volume: |
21 |
Issue: |
2 |
Pages: |
140-2 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
110
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) () phosphorylates serine, threonine and tyrosine residues in proteins such as CRY2, FOXO1 and SIRT1 [, , , ]. It can be activated by tyrosine autophosphorylation [, ]. DYRK1A play a role in a signaling pathway regulating nuclear functions of cell proliferation. DYRK1A is a neurogenesis regulator and plays an important role in altered brain development in Down syndrome [, ]. Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DYRK1B also known as Mirk) also phosphorylates serine, threonine and tyrosine residues, and has been shown to enhance the transcriptional activity of HNF1A and FOXO1 []. Mirk is reported to be an inhibitor of epithelial cell migration [], and appears to mediate carcinoma cell survival in specific environments [].This entry also includes mnb from Drosophila melanogaster. It plays a role in the specific control of proper proliferation of optic lobe neuronal progeny []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) () phosphorylates serine, threonine and tyrosine residues in proteins such as CRY2, FOXO1 and SIRT1 [, , , ]. It can be activated by tyrosine autophosphorylation [, ]. DYRK1A play a role in a signaling pathway regulating nuclear functions of cell proliferation. DYRK1A is a neurogenesis regulator and plays an important role in altered brain development in Down syndrome [, ]. Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DYRK1B also known as Mirk) also phosphorylates serine, threonine and tyrosine residues, and has been shown to enhance the transcriptional activity of HNF1A and FOXO1 []. Mirk is reported to be an inhibitor of epithelial cell migration [], and appears to mediate carcinoma cell survival in specific environments [].This entry also includes mnb from Drosophila melanogaster. It plays a role in the specific control of proper proliferation of optic lobe neuronal progeny [].This entry represents the catalytic domain found in DYRK1A and DYRK1B. |
|
•
•
•
•
•
|
Publication |
First Author: |
Kurabayashi N |
Year: |
2010 |
Journal: |
Mol Cell Biol |
Title: |
DYRK1A and glycogen synthase kinase 3beta, a dual-kinase mechanism directing proteasomal degradation of CRY2 for circadian timekeeping. |
Volume: |
30 |
Issue: |
7 |
Pages: |
1757-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chakravarthy S |
Year: |
2005 |
Journal: |
Mol Cell Biol |
Title: |
Structural characterization of the histone variant macroH2A. |
Volume: |
25 |
Issue: |
17 |
Pages: |
7616-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chadwick BP |
Year: |
2001 |
Journal: |
Nucleic Acids Res |
Title: |
Histone variant macroH2A contains two distinct macrochromatin domains capable of directing macroH2A to the inactive X chromosome. |
Volume: |
29 |
Issue: |
13 |
Pages: |
2699-705 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shindoh N |
Year: |
1996 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Cloning of a human homolog of the Drosophila minibrain/rat Dyrk gene from "the Down syndrome critical region" of chromosome 21. |
Volume: |
225 |
Issue: |
1 |
Pages: |
92-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tejedor FJ |
Year: |
2011 |
Journal: |
FEBS J |
Title: |
MNB/DYRK1A as a multiple regulator of neuronal development. |
Volume: |
278 |
Issue: |
2 |
Pages: |
223-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Park J |
Year: |
2009 |
Journal: |
Cell Mol Life Sci |
Title: |
Function and regulation of Dyrk1A: towards understanding Down syndrome. |
Volume: |
66 |
Issue: |
20 |
Pages: |
3235-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Walte A |
Year: |
2013 |
Journal: |
FEBS J |
Title: |
Mechanism of dual specificity kinase activity of DYRK1A. |
Volume: |
280 |
Issue: |
18 |
Pages: |
4495-511 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kentrup H |
Year: |
1996 |
Journal: |
J Biol Chem |
Title: |
Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. |
Volume: |
271 |
Issue: |
7 |
Pages: |
3488-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hong SH |
Year: |
2012 |
Journal: |
PLoS Genet |
Title: |
Minibrain/Dyrk1a regulates food intake through the Sir2-FOXO-sNPF/NPY pathway in Drosophila and mammals. |
Volume: |
8 |
Issue: |
8 |
Pages: |
e1002857 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tejedor F |
Year: |
1995 |
Journal: |
Neuron |
Title: |
minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. |
Volume: |
14 |
Issue: |
2 |
Pages: |
287-301 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lim S |
Year: |
2002 |
Journal: |
J Biol Chem |
Title: |
Mirk protein kinase is activated by MKK3 and functions as a transcriptional activator of HNF1alpha. |
Volume: |
277 |
Issue: |
28 |
Pages: |
25040-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zou Y |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M. |
Volume: |
278 |
Issue: |
49 |
Pages: |
49573-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee K |
Year: |
2000 |
Journal: |
Cancer Res |
Title: |
Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells. |
Volume: |
60 |
Issue: |
13 |
Pages: |
3631-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang T |
Year: |
2006 |
Journal: |
Nat Struct Mol Biol |
Title: |
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme. |
Volume: |
13 |
Issue: |
7 |
Pages: |
661-2 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE49000 |
Experiment Type: |
transcription profiling by array |
Study Type: |
Baseline |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE40511 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
198
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Sun S |
Year: |
2019 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Sirt6 deacetylase activity regulates circadian rhythms via Per2. |
Volume: |
511 |
Issue: |
2 |
Pages: |
234-238 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
922
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Chung CD |
Year: |
1997 |
Journal: |
Science |
Title: |
Specific inhibition of Stat3 signal transduction by PIAS3. |
Volume: |
278 |
Issue: |
5344 |
Pages: |
1803-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rödel B |
Year: |
2000 |
Journal: |
EMBO J |
Title: |
The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. |
Volume: |
19 |
Issue: |
21 |
Pages: |
5845-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Levy C |
Year: |
2002 |
Journal: |
J Biol Chem |
Title: |
A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. |
Volume: |
277 |
Issue: |
3 |
Pages: |
1962-6 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
75
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Park JH |
Year: |
2014 |
Journal: |
Nat Commun |
Title: |
Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage. |
Volume: |
5 |
|
Pages: |
5483 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sun X |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Characterization of nuclear localization and SUMOylation of the ATBF1 transcription factor in epithelial cells. |
Volume: |
9 |
Issue: |
3 |
Pages: |
e92746 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
MacroH2A is a variant of the major-type core histone H2A which contains an N-terminal H2A domain and a C-terminal nonhistone macro domain. Histone macroH2A is enriched on the inactive X chromosome of mammalian female cells []. It does not bind poly ADP-ribose, but does bind the monomeric SirT1 metabolite O-acetyl-ADP-ribose (OAADPR) with high affinity through its macro domain []. In addition, the macro domain of macroH2A associates with histone deacetylases and affects the acetylation status of nucleosomes. MacroH2A-containing nucleosomes are repressive toward transcription [].The macro domain is a high-affinity ADP-ribose binding module found in a variety of proteins as a stand-alone domain or in combination with other domains like in histone macroH2A and some PARPs (poly ADP-ribose polymerases). Some macro domains recognize poly ADP-ribose as a ligand. Previously identified as displaying an Appr-1"-p (ADP-ribose-1"-monophosphate) processing activity, the macro domain may play roles in distinct ADP-ribose pathways, such as the ADP-ribosylation of proteins, an important post-translational modification which occurs in DNA repair, transcription, chromatin biology, and long-term memory formation, among other processes []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
PIAS3 is an E3-type small ubiquitin-like modifier (SUMO) ligases, stabilising the interaction between UBE2I and Ubc9 respectively and the substrate, and as a SUMO-tethering factor. It plays a crucial role as a transcriptional coregulation in various cellular pathways, including the STAT pathway and the steroid hormone signaling pathway [, , , ].PIAS3 sumoylates CCAR2, promoting its interaction with SIRT1 []and diminishes the sumoylation of ZFHX3 by preventing the colocalization of ZFHX3 with SUMO1 in the nucleus [].SUMO proteins are ubiquitin like proteins that are covalently attached to and detached from other proteins in cells to modify their function. SUMO is first activated in an ATP-dependent reaction by formation of a thioester bond with an E1 (SUMO-activating) enzyme and then transferred to the SUMO conjugating (E2) enzyme Ubc9. Ubc9 catalyses the formation of an isopeptide bond between the C-terminal of SUMO and the amino group of lysine in the target protein. Sumoylated proteins can be targeted for different cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Guan Q |
Year: |
2013 |
Journal: |
PLoS Genet |
Title: |
A nuclear calcium-sensing pathway is critical for gene regulation and salt stress tolerance in Arabidopsis. |
Volume: |
9 |
Issue: |
8 |
Pages: |
e1003755 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Y |
Year: |
2020 |
Journal: |
PLoS Biol |
Title: |
Phase separation of Arabidopsis EMB1579 controls transcription, mRNA splicing, and development. |
Volume: |
18 |
Issue: |
7 |
Pages: |
e3000782 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
181
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
329
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Z |
Year: |
2009 |
Journal: |
J Biol Chem |
Title: |
Inhibition of SUV39H1 methyltransferase activity by DBC1. |
Volume: |
284 |
Issue: |
16 |
Pages: |
10361-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Miki T |
Year: |
2012 |
Journal: |
EMBO J |
Title: |
PML regulates PER2 nuclear localization and circadian function. |
Volume: |
31 |
Issue: |
6 |
Pages: |
1427-39 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li TY |
Year: |
2018 |
Journal: |
Nat Commun |
Title: |
Tip60-mediated lipin 1 acetylation and ER translocation determine triacylglycerol synthesis rate. |
Volume: |
9 |
Issue: |
1 |
Pages: |
1916 |
|
•
•
•
•
•
|
Publication |
First Author: |
Du J |
Year: |
2011 |
Journal: |
Science |
Title: |
Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. |
Volume: |
334 |
Issue: |
6057 |
Pages: |
806-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
von Meyenn F |
Year: |
2013 |
Journal: |
Cell Metab |
Title: |
Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism. |
Volume: |
17 |
Issue: |
3 |
Pages: |
436-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sun C |
Year: |
2020 |
Journal: |
EMBO J |
Title: |
Re-equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction. |
Volume: |
39 |
Issue: |
21 |
Pages: |
e103420 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tiberi L |
Year: |
2014 |
Journal: |
Cancer Cell |
Title: |
A BCL6/BCOR/SIRT1 complex triggers neurogenesis and suppresses medulloblastoma by repressing Sonic Hedgehog signaling. |
Volume: |
26 |
Issue: |
6 |
Pages: |
797-812 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yang K |
Year: |
2022 |
Journal: |
Cell Death Differ |
Title: |
Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. |
Volume: |
29 |
Issue: |
1 |
Pages: |
133-146 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kitamura YI |
Year: |
2005 |
Journal: |
Cell Metab |
Title: |
FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. |
Volume: |
2 |
Issue: |
3 |
Pages: |
153-63 |
|
•
•
•
•
•
|